NCT01493271View on ClinicalTrials.gov

A Study of RO5093151 in Patients With Ocular Hypertension Or Open Angle Glaucoma

PHASE2CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions
Hypertension, Glaucoma, Open-Angle
Interventions
DRUG

Placebo

Placebo to RO5093151

DRUG

RO5093151

oral doses twice daily for up to 28 days

Trial Locations (12)

1115

Budapest

1125

Budapest

1517

Sofia

2500

Esztergom

27262

High Point

29464

Mt. Pleasant

30260

Morrow

500 05

Hradec Králové

570 14

Litomysi

100 34

Prague

401 13

Ústí nad Labem

762 75

Zlín

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01493271 - A Study of RO5093151 in Patients With Ocular Hypertension Or Open Angle Glaucoma | Biotech Hunter | Biotech Hunter